| Dr Jacob Andrew Young, MD/MBA | |
|
7280 W Palmetto Park Rd Ste 305, Boca Raton, FL 33433-3427 | |
| (561) 955-6025 | |
| (561) 955-6069 |
| Full Name | Dr Jacob Andrew Young |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 11 Years |
| Location | 7280 W Palmetto Park Rd Ste 305, Boca Raton, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265877484 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | ME139767 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reynolds Memorial Hospital | Glen dale, WV | Hospital |
| Princeton Community Hospital | Princeton, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Princeton Community Hospital Assn. Inc. | 3678482221 | 133 |
| Reynolds Memorial Hospital, Inc | 9830184530 | 122 |
News Archive
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.
A study which will be published in the May 2014 issue of Experimental Biology and Medicine was aimed at determining whether an EGFR-targeted therapy combined with chemo-radiotherapy can improve local tumor control effectively, compared to cytotoxic agents or irradiation alone.
University of South Florida researchers have suggested a new view of how stem cells may help repair the brain following trauma. In a series of preclinical experiments, they report that transplanted cells appear to build a "biobridge" that links an uninjured brain site where new neural stem cells are born with the damaged region of the brain.
New understanding of the dynamic interplay between genes and environment, made possible by technologies arising from the Human Genome Project, helps support the individualization of medicine and makes focusing on racial or ethnic group differences in disease less relevant, say Penn State researchers.
"Another victim from attacks on U.N.-backed anti-polio teams in Pakistan died on Thursday, bringing the three-day death toll in the wave of assaults on volunteers vaccinating children across the country to nine, officials said," the Associated Press reports (Khan, 12/20). "Four female health workers were killed in Karachi, shot dead by masked men on motorbikes.
› Verified 8 days ago
| Entity Name | Princeton Community Hospital Assn. Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093917643 PECOS PAC ID: 3678482221 Enrollment ID: O20031211000436 |
News Archive
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.
A study which will be published in the May 2014 issue of Experimental Biology and Medicine was aimed at determining whether an EGFR-targeted therapy combined with chemo-radiotherapy can improve local tumor control effectively, compared to cytotoxic agents or irradiation alone.
University of South Florida researchers have suggested a new view of how stem cells may help repair the brain following trauma. In a series of preclinical experiments, they report that transplanted cells appear to build a "biobridge" that links an uninjured brain site where new neural stem cells are born with the damaged region of the brain.
New understanding of the dynamic interplay between genes and environment, made possible by technologies arising from the Human Genome Project, helps support the individualization of medicine and makes focusing on racial or ethnic group differences in disease less relevant, say Penn State researchers.
"Another victim from attacks on U.N.-backed anti-polio teams in Pakistan died on Thursday, bringing the three-day death toll in the wave of assaults on volunteers vaccinating children across the country to nine, officials said," the Associated Press reports (Khan, 12/20). "Four female health workers were killed in Karachi, shot dead by masked men on motorbikes.
› Verified 8 days ago
| Entity Name | Reynolds Memorial Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518068014 PECOS PAC ID: 9830184530 Enrollment ID: O20040420000896 |
News Archive
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.
A study which will be published in the May 2014 issue of Experimental Biology and Medicine was aimed at determining whether an EGFR-targeted therapy combined with chemo-radiotherapy can improve local tumor control effectively, compared to cytotoxic agents or irradiation alone.
University of South Florida researchers have suggested a new view of how stem cells may help repair the brain following trauma. In a series of preclinical experiments, they report that transplanted cells appear to build a "biobridge" that links an uninjured brain site where new neural stem cells are born with the damaged region of the brain.
New understanding of the dynamic interplay between genes and environment, made possible by technologies arising from the Human Genome Project, helps support the individualization of medicine and makes focusing on racial or ethnic group differences in disease less relevant, say Penn State researchers.
"Another victim from attacks on U.N.-backed anti-polio teams in Pakistan died on Thursday, bringing the three-day death toll in the wave of assaults on volunteers vaccinating children across the country to nine, officials said," the Associated Press reports (Khan, 12/20). "Four female health workers were killed in Karachi, shot dead by masked men on motorbikes.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jacob Andrew Young, MD/MBA 5500 N Military Trl Apt 357, Boca Raton, FL 33496-3563 Ph: (561) 504-8453 | Dr Jacob Andrew Young, MD/MBA 7280 W Palmetto Park Rd Ste 305, Boca Raton, FL 33433-3427 Ph: (561) 955-6025 |
News Archive
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.
A study which will be published in the May 2014 issue of Experimental Biology and Medicine was aimed at determining whether an EGFR-targeted therapy combined with chemo-radiotherapy can improve local tumor control effectively, compared to cytotoxic agents or irradiation alone.
University of South Florida researchers have suggested a new view of how stem cells may help repair the brain following trauma. In a series of preclinical experiments, they report that transplanted cells appear to build a "biobridge" that links an uninjured brain site where new neural stem cells are born with the damaged region of the brain.
New understanding of the dynamic interplay between genes and environment, made possible by technologies arising from the Human Genome Project, helps support the individualization of medicine and makes focusing on racial or ethnic group differences in disease less relevant, say Penn State researchers.
"Another victim from attacks on U.N.-backed anti-polio teams in Pakistan died on Thursday, bringing the three-day death toll in the wave of assaults on volunteers vaccinating children across the country to nine, officials said," the Associated Press reports (Khan, 12/20). "Four female health workers were killed in Karachi, shot dead by masked men on motorbikes.
› Verified 8 days ago
Dr. Marc E Taub, M.D. Urology Medicare: Medicare Enrolled Practice Location: 701 Nw 13th St, Third Floor, Boca Raton, FL 33486 Phone: 561-955-5790 Fax: 561-955-5791 | |
David Schwartzwald, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1601 Clint Moore Rd, Suite 195, Boca Raton, FL 33487 Phone: 561-939-0700 Fax: 561-483-8706 | |
Dr. Angelos N Manganiotis, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 7280 W Palmetto Park Rd, Suite 305, Boca Raton, FL 33433 Phone: 561-955-6025 Fax: 561-955-6069 | |
Dr. Laura Maria Tellechea, MD MPF FACOG Urology Medicare: Accepting Medicare Assignments Practice Location: 875 Meadows Rd Ste 325, Boca Raton, FL 33486 Phone: 561-395-4456 Fax: 561-395-4457 | |
Dr. Jeffrey I Miller, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10 E Palmetto Park Rd, Boca Raton, FL 33432 Phone: 561-955-2330 | |
Dr. Ari D Silverstein, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 701 Nw 13th St Fl 3, Boca Raton, FL 33486 Phone: 561-955-5790 Fax: 561-955-5791 |